Resources

The latest in from biologics discovery and development through to production and supply chain management.

Biologics Analysis

Mass Spectrometry: Shortening Time Scales and Progressing Towards Automation

Discover the top bioanalysis presentations from Biologics UK 2022.
Biologics Analysis

Turbocharging Potency Assays – Challenges and Opportunities from Multispecific Drug Modalities

The development of multispecific drugs is an inherently complex and challenging process. Barbara Hebeis of AstraZeneca talks us through challenges surrounding the development of appropriate potency assays, and the opportunities the field offers.
Biologics Analysis

The Black Box Effect - How Can AI and ML Provide Transparent Insights for Drug Discovery?

We interview Martin Akerman, Chief Technology Officer and Co-Founder at Envisagenics to find out about machine learning for drug target discovery in RNA.
Biologics Analysis

Nature Announces Top 10 R&D Institutes

The 2021 report is in, but who made the cut?
Biologics Analysis

The Countdown Begins: How ADCs will Become the Next Generation of Biologics Therapeutics

Key opinion leaders from AbbVie, Ambrx Inc, and Antikor Biopharma talk about the cutting-edge technology’s promise for better therapeutic index.
Biologics Analysis

Biotage® PhyPrep

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics